Author details

Full Name

Keisuke Maeshima

Affiliation

ORCID

Career Start Year

2008

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37819922	Anifrolumab for refractory lupus erythematosus panniculitis in systemic lupus erythematosus.		2023
35485445	Comprehensive lipidomics of lupus-prone mice using LC-MS/MS identifies the reduction of palmitoylethanolamide that suppresses TLR9-mediated inflammation.	Genes to Cells	2022
34319605	Factors Influencing Plasma Coproporphyrin-I Concentration as Biomarker of OATP1B Activity in Patients With Rheumatoid Arthritis.	Clinical Pharmacology and Therapeutics	2021
33560182	Effectiveness of subcutaneous tocilizumab in refractory adult Still's disease: report of three cases and a review of the literature.	Modern Rheumatology Case Reports	2021
31900301	Efficacy of JAK 1/2 inhibition in the treatment of diffuse non-scarring alopecia due to systemic lupus erythematosus.	Annals of the Rheumatic Diseases	2020
31154449	Dr. Maeshima, reply.	Journal of Rheumatology	2019
30442829	An Adult Fatal Case with a Gain-of-function Mutation Associated with Multiple Autoimmune Diseases.	Journal of Rheumatology	2019
30092695	l-Leucine influx through Slc7a5 regulates inflammatory responses of human B cells via mammalian target of rapamycin complex 1 signaling.	Modern Rheumatology	2019
29765031	Comprehensive epigenetic landscape of rheumatoid arthritis fibroblast-like synoviocytes.	Nat Commun	2018
25736357	Large-vessel involvement in granulomatosis with polyangiitis successfully treated with rituximab: A case report and literature review.	Modern Rheumatology	2017
28756864	Preparation and characterization of carbonic anhydrase-conjugated liposomes for catalytic synthesis of calcium carbonate particles.	Enzyme and Microbial Technology	2017
27725555	Familial Mediterranean Fever with Rheumatoid Arthritis Complicated by Pulmonary Paragonimiasis.	Internal Medicine	2016
27275015	Abnormal <i>PTPN11</i> enhancer methylation promotes rheumatoid arthritis fibroblast-like synoviocyte aggressiveness and joint inflammation.	JCI Insight	2016
27159840	LBH Gene Transcription Regulation by the Interplay of an Enhancer Risk Allele and DNA Methylation in Rheumatoid Arthritis.	Arthritis Rheumatol	2016
24517518	Successful leukocytapheresis therapy in a patient with rheumatoid arthritis on maintenance hemodialysis.	Modern Rheumatology	2015
24881751	Steroid-sparing effects of etanercept in a patient with steroid-dependent adult-onset Still's disease.	Internal Medicine	2014
24441153	Effects of tofacitinib on lymphocytes in rheumatoid arthritis: relation to efficacy and infectious adverse events.	Rheumatology	2014
23920268	Successful treatment of refractory anti-signal recognition particle myopathy using abatacept.	Rheumatology	2014
23717000	BehÃ§et's disease complicated by multiple aseptic abscesses of the liver and spleen.		2013
24190148	Congenital intrahepatic portosystemic venous shunt presenting with paraparesis as the initial symptom.	Internal Medicine	2013
22147632	The JAK inhibitor tofacitinib regulates synovitis through inhibition of interferon-Î³ and interleukin-17 production by human CD4+ T cells.		2012
22433919	Successful tocilizumab and tacrolimus treatment in a patient with rheumatoid arthritis complicated by systemic lupus erythematosus.	Lupus	2012
22576568	[Anti-rheumatic effect of JAK-inhibitors].	Japanese Journal of Clinical Immunology	2012
22374445	[Regulation of inflammation through JAK3-Stat6 pathway in dendritic cells].	Japanese Journal of Clinical Immunology	2012
21670967	Adult-onset Still's disease with macrophage activation syndrome successfully treated with a combination of methotrexate and etanercept.	Modern Rheumatology	2012
21360521	Human mesenchymal stem cells inhibit osteoclastogenesis through osteoprotegerin production.		2011
19069122	[Calcineurin-inhibitor induced pain syndrome (CIPS) in an adult-onset Still's disease patient].	Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine	2008